Abstract
In a recent paper, we reported that glucokinase in pancreatic islets might be a critical site which mediates the inhibition of glucose-stimulated insulin secretion by alloxan and ninhydrin. The action mechanisms of the two agents on rat liver glucokinase (instead of islet glucokinase) were studied here.Both alloxan and ninhydrin irreversibly inhibited rat liver glucokinase in concentration-dependent manners. The inhibitory effects of alloxan and ninhydrin on glucokinase were blocked by the presence of hexoses (D-glucose and D-mannose) that serve as substrates of the enzyme. The blockade provided by D-glucose showed α-anomeric preference, as was also observed in the phosphorylation of D-glucose by glucokinase. Protection against the inhibition of glucokinase by alloxan or ninhydrin was also afforded by D-mannoheptulose, a competitive inhibitor of the enzyme with respect to D-glucose. These results suggest that the inhibitory sites of alloxan and ninhydrin are at or near the substrate-binding site of glucokinase.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
